Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.

Bantis, Athanasios

Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies. [electronic resource] - Tumori - 479-83 p. digital

Publication Type: Journal Article

2038-2529

10.1177/030089161109700411 doi


Aged
Aged, 80 and over
Bisphosphonate-Associated Osteonecrosis of the Jaw--diagnosis
Bone Density Conservation Agents--administration & dosage
Bone Neoplasms--diagnostic imaging
Diphosphonates--administration & dosage
Drug Administration Schedule
Humans
Imidazoles--administration & dosage
Infusions, Intravenous
Magnetic Resonance Imaging
Male
Prostatic Neoplasms--pathology
Radionuclide Imaging
Radiopharmaceuticals
Technetium Tc 99m Medronate
Tomography, X-Ray Computed
Zoledronic Acid